Mie K. Azuma
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Feasibility of Reconstructing Survival Outcomes from Unstructured Electronic Medical Records under Japan's Next-Generation Medical Infrastructure Act: A Historical Cohort Study of Atezolizumab in Non-small Cell Lung Cancer.
Journal: Drugs - real world outcomes
Published: July 02, 2026
Simulation of Alzheimer's diagnostic flows with blood biomarker test options in Japan.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: May 14, 2025
Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan: A Patient-Level Simulation.
Journal: Neurology and therapy
Published: March 25, 2023
Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: A model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents - CORRIGENDUM.
Journal: Psychological medicine
Published: June 30, 2022
Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents.
Journal: Psychological medicine
Published: May 04, 2022
Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real-world clinical practice.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 15, 2021
Treatment patterns and medical costs after hepatectomy in real-world practice for patients with hepatocellular carcinoma in Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 15, 2021
Economic Burden of Alzheimer's Disease Dementia in Japan.
Journal: Journal of Alzheimer's disease : JAD
Published: March 29, 2021
Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
Journal: Journal of Alzheimer's disease : JAD
Published: March 29, 2021
Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial.
Journal: Value in health regional issues
Published: April 03, 2020
Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan.
Journal: Journal of gastroenterology
Published: November 02, 2018
Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan.
Journal: Value in health regional issues
Published: May 01, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026